The SOD2 promoter has been shown to have a higher frequency of methylation in a number of cancer cell lines including multiple myeloma, breast and pancreatic cell lines with low SOD2 expression [52,65,66,69]. The gene discussed is SOD2; the disease is plasma cell myeloma.